Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not DisclosedBenzinga • 01/19/22
Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLCPRNewsWire • 01/19/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkgo Bioworks Holdings, Inc. - DNAPRNewsWire • 01/18/22
DNA FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action Commenced by the Firm - DNA, SRNewsfile Corp • 01/17/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - (DNA)Newsfile Corp • 01/17/22
DNA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Ginkgo Bioworks Holdings, Inc.Newsfile Corp • 01/17/22
DNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 18, 2022 in the Class Action Filed on Behalf of Ginkgo Bioworks Holdings, Inc. Limited ShareholdersNewsfile Corp • 01/16/22
DNA DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Ginkgo Bioworks Holdings, Inc. of Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 01/16/22
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - DNANewsfile Corp • 01/16/22
DNA Final Deadline: Rosen, Globally Recognized Investor Counsel, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important January 18 Deadline in Securities Class Action CommenNewsfile Corp • 01/14/22
Deadline Tuesday Notice: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 01/14/22
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc.Business Wire • 01/14/22
Deadline Tuesday Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 01/13/22
DNA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces January 18, 2022 Deadline in Securities Fraud Class Action Lawsuit Filed Against of Ginkgo Bioworks Holdings, Inc. InvestorsPRNewsWire • 01/13/22
Tuesday Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 01/12/22
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DNA Investors of Upcoming Deadline and Urges Investors with Substantial Losses to Contact the FirmNewsfile Corp • 01/12/22
Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business ReviewPRNewsWire • 01/12/22
Ginkgo Bioworks Holdings, Inc. (DNA) Could Find Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 01/11/22
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - DNAPRNewsWire • 01/10/22
Ginkgo Bioworks Adopts Inscripta's Onyx Digital Genome Engineering Platform to Continue Accelerating its Genome Editing ThroughputBusiness Wire • 01/10/22
Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy CapsidsPRNewsWire • 01/10/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important January 18 Deadline in Securities Class Action Commenced by the Firm - DNA, SRNGPRNewsWire • 01/07/22
Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic HeparinPRNewsWire • 01/06/22